(VUZI) Vuzix Cmn Stk - Overview
Sector: Technology | Industry: Consumer Electronics | Exchange: NASDAQ (USA) | Market Cap: 390m USD | Total Return: 59.2% in 12m
Avg Turnover: 8.22M
Qual. Beats: 0
Rev. Trend: -82.7%
Qual. Beats: 0
Warnings
Interest Coverage Ratio -554.5 is critical
Altman Z'' -15.00 < 1.0 - financial distress zone
Fakeout Choppy
Tailwinds
Rs Leader, Idiosyncratic Leader
Vuzix Corporation (VUZI) designs and manufactures augmented reality (AR) wearable technology and smart glasses, including the M Series, Vuzix Blade, and Vuzix Shield. The company’s business model focuses on both direct hardware sales and providing original equipment manufacturer (OEM) component solutions, such as waveguide optics and display engines. Vuzix serves diverse end-markets including enterprise logistics, medical, defense, and security.
The consumer electronics sub-industry is currently shifting toward industrial AR applications where hands-free computing improves operational efficiency in warehousing and telemedicine. Vuzix operates as a vertically integrated manufacturer, maintaining proprietary control over its waveguide production facilities in New York to ensure quality for its military and enterprise clients.
Investors can evaluate the company’s long-term valuation metrics and growth potential by reviewing the data available on ValueRay.
- OEM and ODM partnership expansion drives waveguide and display engine revenue growth
- Enterprise adoption of AR smart glasses determines core hardware sales volume
- Engineering services contracts provide high-margin revenue and technology development funding
- Research and development spending levels impact path toward sustained operational profitability
- Strategic pivot toward AI-integrated wearable technology influences long-term market valuation
| Net Income: -30.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.61 > 0.02 and ΔFCF/TA -3.33 > 1.0 |
| NWC/Revenue: 341.1% < 20% (prev 365.2%; Δ -24.09% < -1%) |
| CFO/TA -0.54 > 3% & CFO -20.9m > Net Income -30.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 6.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (81.9m) vs 12m ago 7.42% < -2% |
| Gross Margin: -26.02% > 18% (prev -0.99%; Δ -2.50k% > 0.5%) |
| Asset Turnover: 16.43% > 50% (prev 14.91%; Δ 1.52% > 0%) |
| Interest Coverage Ratio: -554.5 > 6 (EBITDA TTM -27.6m / Interest Expense TTM 55.3k) |
| A: 0.54 (Total Current Assets 24.8m - Total Current Liabilities 4.01m) / Total Assets 38.4m |
| B: -10.61 (Retained Earnings -407.0m / Total Assets 38.4m) |
| C: -0.83 (EBIT TTM -30.7m / Avg Total Assets 37.1m) |
| D: -92.97 (Book Value of Equity -406.9m / Total Liabilities 4.38m) |
| Altman-Z'' = -134.2 = D |
| DSRI: 0.74 (Receivables 1.47m/1.74m, Revenue 6.09m/5.33m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.87 (AQ_t 0.11 / AQ_t-1 0.13) |
| SGI: 1.14 (Revenue 6.09m / 5.33m) |
| TATA: -0.26 (NI -30.7m - CFO -20.9m) / TA 38.4m) |
| Beneish M = -3.48 (Cap -4..+1) = AA |
As of June 01, 2026, the stock is trading at USD 4.60 with a total of 4,347,077 shares traded.
Over the past week, the price has changed by -2.13%,
over one month by +59.72%,
over three months by +64.29% and
over the past year by +59.17%.
Vuzix Cmn Stk has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy VUZI.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 6 | 30.4% |
P/S = 70.1747
P/B = 17.8133
Revenue TTM = 6.09m USD
EBIT TTM = -30.7m USD
EBITDA TTM = -27.6m USD
Long Term Debt = 371k USD (estimated: total debt 872k - short term 501k)
Short Term Debt = 501k USD (from shortTermDebt, last quarter)
Debt = 872k USD (from shortLongTermDebtTotal, last quarter) (leases 872k already included)
Net Debt = -19.3m USD (calculated: Debt 872k - CCE 20.2m)
Enterprise Value = 370.7m USD (390.0m + Debt 872k - CCE 20.2m)
Interest Coverage Ratio = -554.5 (Ebit TTM -30.7m / Interest Expense TTM 55.3k)
EV/FCF = -15.73x (Enterprise Value 370.7m / FCF TTM -23.6m)
FCF Yield = -6.36% (FCF TTM -23.6m / Enterprise Value 370.7m)
FCF Margin = -386.9% (FCF TTM -23.6m / Revenue TTM 6.09m)
Net Margin = -504.1% (Net Income TTM -30.7m / Revenue TTM 6.09m)
Gross Margin = -26.02% ((Revenue TTM 6.09m - Cost of Revenue TTM 7.68m) / Revenue TTM)
Gross Margin QoQ = -56.62% (prev 16.74%)
Tobins Q-Ratio = 9.66 (Enterprise Value 370.7m / Total Assets 38.4m)
Interest Expense / Debt = 6.34% (Interest Expense 55.3k / Debt 872k)
Taxrate = 21.0% (US default 21%)
NOPAT = -24.2m (EBIT -30.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.19 (Total Current Assets 24.8m / Total Current Liabilities 4.01m)
Debt / Equity = 0.03 (Debt 872k / totalStockholderEquity, last quarter 34.0m)
Debt / EBITDA = 0.70 (negative EBITDA) (Net Debt -19.3m / EBITDA -27.6m)
Debt / FCF = 0.82 (negative FCF - burning cash) (Net Debt -19.3m / FCF TTM -23.6m)
Total Stockholder Equity = 35.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -82.84% (Net Income -30.7m / Total Assets 38.4m)
RoE = -6.95% (Net Income TTM -30.7m / Total Stockholder Equity 442.1m)
RoCE = -6.93% (EBIT -30.7m / Capital Employed (Equity 442.1m + L.T.Debt 371k))
RoIC = -69.45% (negative operating profit) (NOPAT -24.2m / Invested Capital 34.9m)
WACC = 17.33% (E(390.0m)/V(390.9m) * Re(17.36%) + D(872k)/V(390.9m) * Rd(6.34%) * (1-Tc(0.21)))
Discount Rate = 17.36% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 76.41 | Cagr: 11.01%
[DCF] Fair Price = unknown (Cash Flow -23.6m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.28 | # QB: 0
Revenue Correlation: -82.70 | Revenue CAGR: -30.92% | SUE: 0.08 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.11 | Chg30d=-10.00% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=-0.11 | Chg30d=+0.00% | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=-0.42 | Chg30d=+0.00% | Revisions=-20% | GrowthEPS=+0.0% | GrowthRev=+83.0%